Navigation Links
Terumo Cardiovascular Group Announces New President and CEO, Robert DeRyke
Date:4/6/2017

ANN ARBOR, Mich., April 6, 2017 /PRNewswire/ -- Terumo Cardiovascular (CV) Group today announced that Robert (Rob) DeRyke has been appointed President and CEO of Terumo CV Group, effective April 1, 2017, following the retirement of long-time President and CEO Mark Sutter. In this position, DeRyke will lead Terumo's global business related to the cardiopulmonary bypass market including Terumo Cardiovascular Systems (CVS), CV Group's operating company in the United States.

Prior to this appointment, DeRyke served as President of Terumo CV Group's Electromechanical (EM) Systems Division. "Under his leadership, Rob brought stability and improved profitability to the business," said Shinjiro Sato, President and CEO of Terumo Corporation, Terumo CV Group's parent company.

Robert (Rob) DeRyke, President and CEO, Terumo Cardiovascular Group
Robert (Rob) DeRyke, President and CEO, Terumo Cardiovascular Group

DeRyke takes lead of a company with deep expertise in the cardiac arena, well positioned for the future.

"We have a strong foundation of talent, technologies, and systems to build on as we deliver long-term value to our customers and their patients," said DeRyke.

Terumo CV Group is building momentum that will create a positive impact for healthcare providers and the critically ill patients they serve.  Having recently cleared the shipping restrictions imposed as a condition of its 2011 consent decree, the company is preparing to return its flagship Terumo® Advanced Perfusion System 1 heart-lung machine to market in June 2017. As a market leader in oxygenators and cardiac monitoring technologies, Terumo CV Group will introduce its newest CAPIOX® oxygenator and CDI® inline blood gas monitoring system later this year, reinforcing the company's commitment to the global cardiac community.

DeRyke joined Terumo in 2012 as Vice President of Corporate Quality for Terumo CVS. He has over 25 years' experience in medical devices and pharmaceuticals, and has held executive leadership positions for Baxter Healthcare, Hospira, and Thermo-Fisher Scientific. He holds a Master of Business Administration from Michigan State University and a Bachelor of Science in Chemistry from Western Michigan University.

About Terumo Cardiovascular Group

Terumo Cardiovascular Group manufactures and markets medical devices for cardiac and vascular surgery with an emphasis on cardiopulmonary bypass, intra-operative monitoring and vascular grafting. The company is headquartered in Ann Arbor, Michigan, with manufacturing operations in the U.S., Europe and Asia. It is one of several subsidiaries of Terumo Corporation of Japan that is focused exclusively on cardiac and vascular specialties. For more information, visit www.terumo-cvgroup.com.

About Terumo Corporation

Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with over $5 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use. Terumo contributes to society by providing valued products and services to the health care market and by responding to the needs of health care providers and the people they serve. Terumo Corporation's shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol <4543.T>, or Bloomberg 4543: JP) and is a component of the Nikkei 225, Japan's leading stock index.

Terumo and CAPIOX are registered trademarks of Terumo Corporation. CDI is a registered trademark of Terumo Cardiovascular Systems.

879978

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/terumo-cardiovascular-group-announces-new-president-and-ceo-robert-deryke-300436270.html


'/>"/>
SOURCE Terumo Cardiovascular Group
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp.
2. Global Coronary Stents Market 2014-2018: Key Vendors are Abbott, Boston Scientific, Medtronic and Terumo
3. Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating
4. OrbusNeich Announces Favorable Ruling from the European Patent Office and Initiation of Litigation Against Terumo Corporation
5. Abiomed Inc., HeartWare International and Terumo Corporation Battling out for the top Spot in the Cardiac Assist Devices Market
6. MC3 Cardiopulmonary Acquires Surgical Cannula Product Assets from Terumo Cardiovascular Systems
7. Global Coronary Artery Disease Treatment Devices Market 2015-2019 - Key Vendors are Abbott Vascular, Boston Scientific, Medtronic & Terumo
8. Terumo BCT Announces a $17.4 Million Funding Contract from the Biomedical Advanced Research and Development Authority (BARDA)
9. Research and Markets - Global Intravenous (IV) Solutions Market Analysis 2016 - Forecast to 2022 - Key Players are Widatra Bhakti, Vifor Pharma & Terumo
10. Terumo Showcases Radial Access Portfolio at American College of Cardiology Conference
11. The Global Cardiovascular Drugs Market to Decline at a CAGR of 10.47 Percent Over the Period 2012-2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2018)... ... August 03, 2018 , ... Flexefits, a pioneer in direct ... especially for its allowing participants in Direct Primary Care arrangements to keep HSA eligibility ... at $150 per individual and $300 per family per month.) , “We are very ...
(Date:8/3/2018)... ... , ... In order to improve safety for everyone throughout the summer, personal ... significant risks of injury that many amusement park rides present during the summer months. ... a thrilling ride on a roller coaster. Unfortunately, these fun times can quickly turn ...
(Date:8/2/2018)... ... 02, 2018 , ... What: The Wharton School is pleased to invite business ... up to five business reporters who cover aspects of public policy to attend the ... Each funding opportunity covers the cost of tuition, course materials, most group meals, lodging ...
Breaking Medicine Technology:
(Date:8/14/2018)... IRVINE, Calif. (PRWEB) , ... August 14, 2018 ... ... nation’s leading dental support organizations (DSO) with nearly 400 affiliated offices across 16 ... & Orthodontics in San Diego, California. , Smile Brands will provide full-service ...
(Date:8/11/2018)... ... August 10, 2018 , ... TopConsumerReviews.com recently awarded a five-star ... gout? This painful, persistent condition originates in the liver and is characterized by ... acid. Other contributing factors may be medication side effects, overweight, and unhealthy diet. ...
(Date:8/9/2018)... ... August 09, 2018 , ... Thousands of ... ruptured, according to cross-referenced data from The American Society of Plastic Surgeons (ASPS), ... rates monitored by the FDA. As an MRI is recommended by FDA after ...
(Date:8/9/2018)... ... August 09, 2018 , ... RiverGlade Capital (“RiverGlade”), is ... and will have an exclusive relationship with the firm. As an Operating ... human capital sourcing, and deal origination, evaluation and diligence. He brings a ...
(Date:8/7/2018)... , ... August 07, 2018 , ... ... its line of Nancy’s Probiotic Foods. These rich, cream-on-top-style yogurts are made with ... grains, yielding milk that's high in omega-3 fatty acids. Nancy’s sources the milk ...
Breaking Medicine News(10 mins):